Gallstone disease screening

Gallstone disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gallstone disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery Lithotripsy Surgical management
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gallstone disease screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gallstone disease screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gallstone disease screening
CDC on Gallstone disease screening
Gallstone disease screening in the news
Blogs on Gallstone disease screening
Directions to Hospitals Treating Gallstone disease
Risk calculators and risk factors for Gallstone disease screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: {{HM}]

Overview

Early treatment of Gallstone disease decreases the morbidity or avoids further cholecystectomy, which in turn may offset the need for screening, since patients would have to finance an it may save clinical care costs in later disease periods sufficiently to offset the screening and early treatment costs. In addition, whether routine screening for GSD is worthwhile depends on whether patients are willing to pay the ultrasonography screening cost that would reduce the risk of cholecystectomy.

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Screening

• There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

• According to the [guideline name], screening for [disease name] is not recommended.

OR

• According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
  • [Condition 1]
  • [Condition 2]
  • [Condition 3]